Dr. Sharon K. Cole, MD

Dr. Cole practices at Blanchard Valley Hospital in Findlay, Ohio, part of Blanchard Valley Health System.

Dr. Cole's NPI, 1942293873, was assigned on August 25, 2005. Dr. Cole graduated from Ohio State University College of Medicine in 1990. Dr. Cole holds Ohio license 35061936.

Dr. Cole's primary practice is Blanchard Valley Hospital, at 1900 South Main Street, Findlay, OH 45840 in Hancock County. The practice phone is (419) 423-4500.

Dr. Cole's primary practice is Blanchard Valley Hospital in Findlay, Ohio, part of Blanchard Valley Health System. Dr. Cole is also affiliated with Mercy Health - St. Rita's Medical Center. The medical group on file is Blanchard Valley Hospital. Dmand AI also links Dr. Cole to 2 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account. Dr. Cole's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cole practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Cole's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Cole is licensed in Ohio.

CMS data shows 843 Medicare services from Dr. Cole across 3 procedure codes in 2024, all of them office visits, for 364 Medicare patients. Medicare paid $79,396 for them. Every service was in an office.

CMS counts 364 Medicare patients who saw Dr. Cole in 2024. The largest group is 65 to 74, with 159 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cole's median patient age at 74, with 67% women.

In 2024, Dr. Cole wrote 1,585 Medicare Part D claims for 270 patients. 73% of them were for generic drugs. CMS names the drug for 1,362 of them, across 37 drugs with 11 or more claims each, at $4,328,544 in total drug cost. In 2023, CMS named 1,178 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 68 out of 100 for Dr. Cole for performance year 2024, reported as part of a group. Dr. Cole accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cole as offering telehealth.

Dmand AI links 4 papers to Dr. Cole, published from 2019 to 2021. 2019 was the busiest year, with 2. The most frequent topics are Breast Neoplasms and Inflammation. Dr. Cole's most frequent co-authors are Supriya Gupta Mohile, MD, Benjamin T. Esparaz, MD and Jeffrey Kent Giguere, MD.

CMS Open Payments shows 1,474 general payments to Dr. Cole from 70 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,865.

Dr. Cole graduated from Ohio State University College of Medicine in 1990.